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A novel fluorescent competitive inhibitor of adenosine d aminase (EC 3.5.4.4) (ADA), I-Wetheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine 
(E-EHNA), is protonated at the active site of the enzyme. In E-EHNA [&=(4.06 + 1.00) 1O-6 M] part of the competive inhibition of EHNA 
is combined with spectroscopic properties of etheno-adenines. Computer subtraction of the fluorescence xcitation spectrum of ADA from that 
of its equimolar complex with e-EHNA yielded the corrected excitation spectrum of o-EHNA at the active site of the enzyme. This spectrum mimics 
that of E-EHNA at pH 5.5 in buffer solution and is suggested to indicate a shift in protonation equilibrium at the active site. 
Adenosine deaminase; I-W-Etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine; Etheno-adenine; Fluorescent inhibitor; pH indicator; 
Fluorescence polarization 
1. INTRODUCTION 
Adenosine deaminase (EC 3.5.4.4) (ADA) is impor- 
tant for its metabolic role [l-6] (it is absent in severe 
combined immunodeficiency [7]), quaternary polymor- 
phism [8,9], response to malignancy [3,5] and 
availability of tight inhibitors [lo]. Still unknown are 
the amino acid composition at the active site and the 
regulatory role of polymorphism. 
droxy-3-nonyl)] adenine (e-EHNA), which combines 
properties of the two aforementioned groups. More- 
over, it indicates protonation at the active site of ADA. 
EHNA, a classic example of rational design of en- 
zyme inhibitors by Schaeffer et al. [ll] is a tight com- 
petitive inhibitor of ADA (Kr=].6.10e9 M) [12], 
shown to bind to a hydrophobic region adjacent to the 
catalytic site [ 131. 
Fluorescent etheno-adenosine derivatives, initially in- 
troduced by N. Leonard 1141, have been used to probe 
adenine-containing systems, be it nucleic acids or 
energy conserving substrates. Etheno-adenosine, ob- 
tained by reaction of aqueous chloroacetaldehyde with 
adenosine, is a modification of adenosine at the 6-NHz 
group. It is a highly fluorescent compound with a quan- 
tum yield close to 0.6 and a lifetime of 23 ns [15]. 
Ground state pH indicator equilibria are usually 
detected by absorbance (color). When one is compelled 
to use fluorescent indicators for the sake of sensitivity, 
the corrected fluorescence excitation spectra are iden- 
tical with the absorbance and can yield the same infor- 
mation. This rule, however, is not obeyed in etheno 
adenines 1141, which also have other spectroscopic 
peculiarities [16-181. Nevertheless, the fluorescence x- 
citation spectra are pH dependent and can be calibrated 
with reference to buffered solutions. Thus, the cor- 
rected fluorescence excitation spectrum of e-EHNA 
bound to ADA at the active site resembles that of e- 
EHNA in buffer solution at pH 5.5. This spectrum is 
observed although the pH of the buffered bulk is 7.5. 
The pH dependence of the corrected fluorescence x- 
citation spectra of e-EHNA suggests the following 
ground state protonation equilibrium (fig.1; [19]). 
We report here a novel fluorescent competitive in- 
hibitor of (ADA) [l], 1-N6-etheno-[erythro-9-(2-hy- 
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Abbreviations: ADA, adenosine deaminase; e-EHNA, I-N6-etheno- 
[erythro-9-(2-hydroxy-3-nonyl)] adenine; EHNA, erythro-9-(2-hy- 
droxy-3-nonyl)] adenine; 2’-deoxycoformycin (Pentostatin), [3-(2’- 
deoxy-8-D-erythro-pentofuranosyl)-3,6,7,8-tetr~ydroimidazol[4.5- 
d][ 1,3]diazepin-&(R)-ol] , The abbreviation ‘c’ was introduced by 
Secrist et al. [14] and stands for etheno. 
EHNA was prepared according to Shaeffer and Schwender [l I] and 
Giner-Sorolla [20], with a few modifications [21]; e-EHNA was ob- 
tained by dissolving EHNA (100 mg) in freshly prepared 
chloroacetaldehyde (1.57-1.00 M, pH 4.5) according to Keeler and 
Campbell [22]. Chloroacetaldehyde in aqueous olution at pH 4.5 was 
made according to Secrist iii et al. [14]. The mixture was stirred 48 h 
at room temperature in the dark at constant pH = 4.0-4.5 and checked 
by TLC and U.V. absorbance. Purification was by preparative TLC 
on cellulose. The fluorescent band was extracted with distilled water, 
and cellulose was separated by centrifugation (9980 x g). c-EHNA 
was recrystalized from ethanol and diethyl ether. The single fluores- 
cent spot on TLC (eluent CH2C12/CHsOH, 90/10, v/v) had 
Rr=0.500 [lo]. ‘H NMR (DMSO-d6) ppm 9.44 (s, lH), 8.53 (s, lH), 
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8.25 (d, lH), 7.21 (d, lH), 4.38 (m, lH), 4.00 (m, lH), 3.5 (s, OH), 
0.78-l .80 (m, 16H). 
Adenosine deaminase (high purity grade, from calf intestine, ap- 
proximately 200 units/mg protein, Sigma [8]) activity was determined 
by spectrophotometric assay at 265 nm [9] and by the Berthelot col- 
orimetric assay for ammonia (81. Enzyme kinetics were run at 24 f 
1°C. The concentration of ADA was calculated assuming 
M, = 45 000. ADA was incubated 5 min with either +EHNA, EHNA 
or .+adenosine prior to addition of adenosine. In the spec- 
trophotometric method the concentration of adenosine was varied 
from 1.4. lo-’ to 1.6. 10d4 M. 
Pho&obleaching of ADA was carried out according to the pro- 
cedure described by Parola et al., (Anal. Biochem., in press). 
Corrected fluorescence xcitation spectra were recorded on an SLM 
4800 spectrofluorometer with a depolarizer at the exit of the excita- 
tion monochromator, at an emission wavelength of 400 nm. A con- 
centrated solution of Rhodamine B in propylene glycol was used as 
reference. 
Fluorescence lifetimes were measured on the SLM4800 phase- 
modulation spectrofluorometer as described before [26]. At least 5 
measurements of phase and modulation were accumulated at 6, 18 
and 30 MHz in accumulation time windows of 25 s, and converted in- 
to 7pt,asc and r,,,od by SLM lifetim softwar on an Apple IIe computer. 
Heterogeneity analysis of +haJe and ~,,,~d data was carried out by least- 
squares analysis program ISSC6-87, assuming phase and modulation 
frequency independent measurement errors, @#,a% = 0.2 and 
~~~“,~~i~~ = 0.004, respectively [23). Fluorescence decay curves were 
obtained in a nanosecond single photon correlation spec- 
trofluorometer. The sample was excited with the 316 nm nitrogen 
emission line [24]. 
Steady-state fluorescence polarization measurements of e-EHNA 
as a function of ADA concentration, at 22 f 1 “C, was measured by: 
(i) Perkin-Elmer MPF-44 equipped with dichroic polarizers and emis- 
sion depolarizer, at h., = 3 15 nm , A,, = 400 nm, excitation and emis- 
sion slits were 6 and 20 nm respectively; (2) SLM 4800, T- 
configuration, equipped with dichroic polarizers and depolarizer at 
the exit of the excitation monochromator, at Ao= 315 nm, with either 
350 nm or 400 nm Kodak Wratten sharp cut-off filters in front of the 
emission photomultipliers. Samples were prepared from freshly 
bleached ADA in 63 mM sodium phosphate buffer, pH 7.5. The con- 
centration of e-EHNA was kept constant in all samples (5. lo- 6 M in 
phosphate buffer pH 7.5) while ADA concentration was varied from 
3.33. lo-’ M to 9.45. 10m6 M. The concentration of ADA was deter- 
mined from the blanks (equal concentration of enzyme in the absence 
of e-EHNA) by the spectrophotometric activity assay, assuming a 
molecular weight of 45 000. 
Dynamic polarization of P-EHNA as a function of ADA/f-EHNA 
molar ratio was measured on SLM 4800 at he, = 3 15 nm, at modula- 
tion frequencies of 6 and 30 MHz and T~on~guration (in accumula- 
tion time windows of 25 s, with a depolarizer at the exit of the excita- 
tion monochromator and Kodak Wratten sharp 400 nm cut-off filter 
in front of the emission photomultipliers). Measurements were 
recorded either by rotating the excitation polarizer from 0” to 90’ 
with polarizer in channel A at 0” and polarizer in channel B at 90” or, 
by rotating channel B polarizer from 0” to 90” with polarizers in chan- 
nel A and excitation both at 0. 
3. RESULTS 
The complicated spectroscopic properties of PEHNA 
are similar to those of other e-adenine analogs [14,15]. 
U.V. absorption spectra are pH-dependent and show an 
isosbestic point at 292-294 nm (fig.l), indicating 
equilibrium between protonated and non-protonated 
forms (eq.1). The absorptivity of the strongest band, 
E276 ,,,,,=3570 M-‘cm-‘, is inconveniently low, half 
that of e-adenosine [ 141. Ground state acidity constant, 
p~a~EHNA = 4.03 + 0.19, was derived from absorbance 
vs pH at four different wavelengths. Upon excitation at 
3 15 nm, vibrationally unresolved fluorescence mission 
with X,,, = 407 nm was obtained. Fluorescence lifetime 
measured by single photon correlation and phase 
modulation fluorometry 125) yielded a single lifetime 
7= 27.1 & 0.2 ns, at pH 7.5. Fluorescence intensity was 
also pH dependent and a plot of peak height vs pH 
yielded pKIEHNA = 4.2, close to that in absorption (they 
do not have to be equal). Fig.1 shows corrected 
fluorescence excitation spectra as a function of pH. A 
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Fig. 1. Corrected fluorescence xcitation spectra of +EHNA as a func- 
tion of pH, fluorescence mission at 400 nm. Insert: Dependence of 
U.V. absorbance of eEHNA on pH in buffer. 22 f 1°C; [E-EHNA] = 
0.1 mM. Left of isosbestic point: protonated species; right: un- 
protonated. Fluorescence xcitation differs from UV absorption in 
that the unprotonated form (e.g. pH 7.5) contributes more to 
fluorescence than the protonated one. 
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Fig.2. (Insert) Corrected fluorescence xcitation spectra, in phosphate 
buffer at pH 7.5, at&,= 400 nm and at room temperature, of: (- -) 
r-EHNA:ADA 1:l complex, 1 PM; (---) e-EHNA, 1 ,uM; (-) 
ADA, 1 PM (Mr= 45 000 [24]; laser photobleached, see section 2 and 
(261. (Figure) Full lines: expanded view of l -EHNA:ADA 1: 1 complex 
and l -EHNA of insert. Lower dashed curve: computer subtraction of 
fluorescence xcitation spectrum of ADA from that of the 1: 1 com- 
plex between e-EHNA and ADA of insert. This curve (denoted in the 
figure as (calc)e-EHNA:ADA-ADA) is the spectrum of l -EHNA at 
the active site of ADA. The abscence of the Raman line at 360 nm 
validates the subtraction procedure. This curve mimics that of c- 
EHNA in buffer at pH 5.5. Upper dashed curve: computer addition 
(from insert) of e-EHNA, in buffer at pH 7.5 and ADA, in buffer at 
pH 7.5. This reference spectrum (denoted in the figure as (calc)e- 
EHNA + ADA) represents anon-interacting 1:l mixture. All spectra 
were free of inner filter effect (absorbance < 0.2). 
linear Perrin plot of E-EHNA in glycerol (50% in 
phosphate buffer) yielded limiting anisotropy value 
ro= 0.23. 
c-EHNA is a competitive inhibitor of ADA, KI = (4.0 
f 1 .O) . IO- 6 M. Binding of f-EHNA to photobleached 
ADA (to eliminate non-peptidic fluorescent impurity in 
ADA; the enzyme is unharmed [26]), was studied by 
steady-state and phase modulated fluorescence 
polarization. We observed binding saturation beginning 
at 0.5 ADA/c-EHNA molar ratio. While no change in 
fluorescence mission maxima was noted, the following 
lifetimes were observed: 71= 24.60 + 1.06 ns and 
7~ = 2.90 + 0.42 ns with fractional contributions of 0.80 
and 0.20 (& 0.02) respectively. Binding specificity to 
the active site of ADA was confirmed by competition 
experiments in the presence of 2’-deoxycoformy- 
cin’(Kr=2.5. lO_” M [12]), EHNA (Kt= 1.6. lob9 M 
[12] and adenosine; complete loss of fluorescence 
polarization resulted from competition of inhibitors 
with f-EHNA, while a x 30 concentration of adenosine 
(Km = 2.5 x lo- ’ M) was required for 90% reduction in 
polarization. 
Our results may support the theoretical prediction of 
Warshel [29], who suggested that enzymes can be view- 
ed as ‘super solvents’. The protein can stabilize’ ionic 
states more effectively than aqueous solutions do. Hav- 
ing identified the protonation of f-EHNA, one cannot 
state where the proton comes from. Thus, the lowering 
of pH at the active site would imply the presence of a 
local pool rich in HsO+ segregated from the bulk of the 
buffer. Alternatively, direct protonation by amino acid 
residues may be involved. Whichever is the proton 
donating moiety, fluorescence excitation of c-EHNA, 
measured at steady-state conditions, probes an 
equilibrium and not transients related to catalysis. In 
this equilibrium, the ratio of non-protonated to pro- 
tonated c-EHNA is 25: 1, while at the buffered bulk pH 
of 7.5 this ration is - 3100: 1. Structural restrictions and 
polar interactions could also, in principle, shift the 
fluorescence spectra. Yet, the fluorescence spectra of c- 
adenine analogues are known to be particularly insen- 
‘2’-Deoxycoformycin (Pentostatin) is the strongest known inhibitor 
of ADA. It is a transition state inhibitor with unique affinity to the 
active site. 
Fig.2 shows corrected fluorescence xcitation spectra *or destabilize the neutral form. In either case ApK. - 2 is observed, 
of c-EHNA bound in 1: 1 molar ratio to ADA. The corresponding to 3 k&/mole. 
decline in fluorescence at h = 300 nm relative to that at 
276 nm indicates a shift in the protonation equilibrium 
at the active site of ADA, which resembles that observ- 
ed in buffered solution at pH = 5.2-5.5 (fig.1). 
4. DISCUSSION 
EHNA, the precursor of c-EHNA, had been shown 
to have a peculiar mechanism of inhibition [27]. The in- 
itial step, in which the hydrophobic chain and its 
hydroxyl group are thought to be involved, obeys the 
classical mechanism of competitive inhibition and is 
characterized by a KI of 2. lo- ’ M. Then a consecutive 
rearrangement of either the enzyme or the inhibitor oc- 
curs, yielding a tight ADA-inhibitor complex. Thus 
EHNA is a strong inhibitor of ADA (overall inhibition 
constant 1.61. 10m9 M) in which, remarkably, the 
target 6-NH2 is unaffected. 
Evidently, the conformational modifications occur- 
ring in the ADA-EHNA encounter complex must be 
different from those [28] which, in the ADA-adenosine 
complex, yield the transition-state structures which 
progress towards the product. The distortions of the 
native configurations might determine the destination 
of a molecule as an inhibitor or a substrate. 
The initial characteristics of binding of EHNA to 
ADA may be retained in c-EHNA, in which the 
hydrophobic moiety has not been altered. Thus, the in- 
hibitor senses the environment of the enzyme active 
site, although the protonation to which it is subjected 
may not be directly related to the catalytic mechanism 
of ADA. 
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sitive to solvent polarity [ 14,161. The only documented 
environmental influences on the fluorescence spectra 
are pH and, to a much lesser extent, solvent viscosity 
1141. 
Etheno-adenine analogues have found wide use in 
CAMP binding, release and exchange studies [15]. 
Fluorescent e-adenylated enzymes (i.e. glutamine syn- 
thetase) were used for the determination of distances 
between metal ion binding sites and fluorescent 
nucleoside. Etheno-adenosine analogues have also been 
used for the determination of binding regions of the 
corresponding nucleosides (ATP, AMP) in adenylate 
kinase. These studies were carried out by means of 
fluorescence quenching, energy transfer of U.V. dif- 
ference spectroscopy. 
To the best of our knowledge, this is the first report 
where the peculiar proton sensitivity of an etheno 
analogue has been applied to probe the ‘acidity’ of an 
enzyme active site by means of the relatively sensitive 
steady-state fluorescence xcitation spectroscopy. 
The fluorescence excitation spectrum of enzyme 
bound e-adenosine (the etheno modification of natural 
substrate, adenosine) could not be obtained. ~though 
c-adenosine has an intact ribose moiety, it shows lower 
affinity to ADA (KI= 3. 10e5 M)3. Therefore, the re- 
quirement of equilibrium conditions4 between E- 
adenosine and ADA could not be fulfilled within a con- 
centration range free of inner filter effec?. Thus, as far 
as ADA is concerned, the choice of l -EHNA was ad- 
vantageous. 
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‘We have studied the binding of e-adenosine by Michaelis-Menten 
kinetics and found that it also is a competitive inhibitor of ADA. 
4The equilibrium binding conditions are achieved when the initial con- 
centration of the enzyme is of the same order of magnitude as the 
dissociation constant of the ligand-enzyme complex, which is in this 
case - 10v5 M 1301. 
‘The absorbance of the solution in the given range of wavelengths 
must be less than 0.2 [31]. 
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